Ticker: BCRX

Company: BIOCRYST PHARMACEUTICALS INC

Person: Helen M Thackray, officer

Transaction date: March 31, 2025

Reporting date: April 2, 2025

Average share price: 7.5

Sold 7525.0 shares for 56437.5